AKR1B10 and esophageal adenocarcinoma: AKR1B10 was shown to be upregulated not only in cancers but also in some preneoplastic conditions, such as Barrett’s esophagus (Breton et al., 2008) and squamous metaplasia (Li et al., 2008).